Drug-labels.com

Mint-Tolterodine: Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx)
Strength:
1 mg, 2 mg
Active ingredient:

Patient Medication Information: uses, side effects, how to take - Mint-Tolterodine

What the medication is used for:

The name of this medication is MINT-TOLTERODINE. It is used for the treatment of the symptoms of overactive bladder which include frequency, urgency, and urge incontinence.

REMEMBER: This medication is for YOU. Never give it to others. It may harm them even if their symptoms are the same as yours.

What it does:

Tolterodine prevents bladder contractions or spasms. This results in more bladder capacity and less frequency, urgency and involuntary loss of urine.

When it should not be used:

You should not take MINT-TOLTERODINE if you have:

  • urinary retention,
  • gastric retention
  • uncontrolled narrow angle glaucoma,
  • known hypersensitivity to the tolterodine L-tartrate

    or any of the other ingredients.

What the medicinal ingredient is:

Each tablet contains 1 mg or 2 mg of the active ingredient tolterodine L-tartrate.

What the important nonmedicinal ingredients are: The tablets also contain the following inactive ingredients: Microcrystalline cellulose, dibasic calcium phosphate dihydrate, sodium starch glycolate, colloidal silicon dioxide, magnesium stearate, hypromellose, purified stearic acid, titanium dioxide.

What dosage forms it comes in:

MINT-TOLTERODINE 1 mg tablets are white round, biconvex, film-coated tablets debossed with ‘J’ on one side and ‘157’ on the other side.

MINT-TOLTERODINE 2 mg tablets are round, biconvex, film-coated tablets debossed with ‘J’ on one side and ‘158’ on

the other side.

MINT-TOLTERODINE may have an effect on the electrical activity of the heart. This effect can be measured as a change in the electrocardiogram (ECG). It is important to follow the instructions of your doctor with regard to dosing or any special tests. In very rare cases, drugs with an effect on the ECG can lead to disturbances in heart rhythm (arrhythmias/ dysrhythmias). These heart rhythm disturbances are more likely in patients with risk factors, such as heart disease, or in the presence of certain interacting drugs. If you experience any symptoms of a possible heart rhythm disturbance, such as dizziness, palpitations (sensation of rapid pounding, or irregular heart beat), fainting, or seizures, you should stop taking MINT-TOLTERODINE and seek immediate medical attention.

BEFORE you use MINT-TOLTERODINE talk to your doctor or pharmacist if:

  • you are pregnant, or trying to become pregnant

  • you are breastfeeding your child
  • you have myasthenia gravis (a chronic autoimmune neuromuscular disease which cause muscle weakness)
  • you have stomach problems affecting passage and digestion of food
  • you have liver problems
  • you have kidney problems
  • you are taking medication bought without a prescription.

    They may affect your condition, or how MINT-TOLTERODINE works for you.

  • you are a female or are over 65 years in age; you have a disorder known as Long QT Syndrome; a heart disease; a history of stroke or brain hemorrhage; a personal history of fainting spells; a family history of sudden cardiac death at <50 years; electrolyte disturbances (e.g., low blood potassium levels); an eating disorder or are following an extreme diet; diabetes, especially with associated nerve disorders

The following list includes some, but not all, of the drugs that may increase the risk of side effects while receiving MINT-TOLTERODINE. You should check with your doctor or pharmacist before taking any other medication with MINT-TOLTERODINE.

Drugs that may interact with MINT-TOLTERODINE include:

  • other drugs that possess antimuscarinic/anticholinergic properties (drugs that cause blurred vision, constipation, dry mouth, etc.)
  • antifungals (drugs to treat fungal infections , such as, fluconazole, ketoconazole, or itraconazole) ABOUT THIS MEDICATION

WARNINGS AND PRECAUTIONS

INTERACTIONS WITH THIS MEDICATION

  • antibiotics (ie. erythromycin, clarithromycin)
  • cyclosporine (a drug to prevent rejection of organ

    transplants)

  • vinblastine (a drug to treat some types of cancer)
  • antiarrhythmics (drugs that stabilize the heart rhythm

    function, such as procainamide, quinidine, amiodarone, sotalol etc.)

  • antidepressants (mood disorder drugs)
  • antipsychotics (drugs to stabilize thinking and behavior)
  • anti-asthmatic (salmeterol)

Take MINT-TOLTERODINE as instructed by your doctor. Do not increase, decrease or stop taking MINT-TOLTERODINE without first talking to your doctor.

Usual dose:

The usual starting dose is 2 mg twice daily, but may be decreased to 1 mg twice daily.

Overdose:

Do not take more tablets than your doctor has told you to.

Missed Dose:

If you should forget to take your tablet at the usual time, take it as soon as you remember unless it is time to take the next one. Continue with the remaining doses as before. Do not take more than one dose at a time.

S AND WHAT TO DO ABOUT THEM

As with most drugs, MINT-TOLTERODINE can cause some side effects.

Tell your doctor or pharmacist right away if you suffer from any of the following side effects while taking this medication:

  • dry mouth
  • decreased tear production (dry irritable eye)
  • heartburn
  • blurred vision
  • dizziness
  • palpitations (sensation of rapid, pounding, or irregular

    heart beat)

  • fainting
  • difficulty in urination (passing water)

The most common side effects are dry mouth and headache.

Less commonly reported side effects are dizziness, fatigue, abdominal pain, constipation and heartburn.

If you experience any symptoms of a possible heart rhythm disturbance, such as dizziness, palpitations (sensation of rapid, pounding, or irregular heart beat), fainting, or seizures, you should stop taking MINT-TOLTERODINE and seek immediate medical attention.

Check with your doctor or pharmacist right away if you have any bothersome or unusual effects while taking MINT-TOLTERODINE.

Use caution while driving or using machinery until you know how MINT-TOLTERODINE affects you.

SERIOUS SIDE EFFECTS, HOW OFTEN THEY
HAPPEN AND WHAT TO DO ABOUT THEM
Symptom/effectTalk with your doctor or pharmacistStop taking drug and call your doctor or pharmacist
Only if severeIn all cases
UncommonAllergic reaction√

This is not a complete list of side effects. For any unexpected effects while taking MINT-TOLTERODINE, stop taking the drug and contact your doctor or pharmacist.

Store at room temperature 15ºC to 30ºC.

You should not use your medication after the expiration date printed on the carton and label.

Keep all medications out of the reach of children. This medication could harm them.

PROPER USE OF THIS MEDICATION

If you think you have taken too much MINT-TOLTERODINE, contact your healthcare professional, hospital emergency department or regional poison control centre immediately, even if there are no symptoms.

HOW TO STORE IT

SIDE EFFECTS AND

WHAT TO DO ABOUT THEM

IMPORTANT: PLEASE
READ

If you want more information about MINT-TOLTERODINE:

  • Talk to your healthcare professional
  • Find the full product monograph that is prepared for healthcare professionals and includes this Patient Medication Information by visiting the Health Canada website (https://www.canada.ca/en/health-canada.html); the manufacturer's website

    (www.mintpharmaceuticals.com), or by calling 1-877-398-9696.

Date of Revision: September 9, 2020

REPORTING SIDE EFFECTS

You can report any suspected side effects associated with the use of health products to Health Canada by:

  • Visiting the Web page on Adverse Reaction

    Reporting (https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-canada/adverse-reaction-reporting.html) for information on how to report online, by mail or by fax; or

  • Calling toll-free at 1-866-234-2345.

NOTE: Contact your health professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice.

MORE INFORMATION

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02423308

Revision date stated in the text: September 9, 2020

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Mint-Tolterodine

Rx or OTC
Prescription (Rx)?
DIN 02423308, 02423316
Schedule(s) PRESCRIPTION
Active ingredient(s) Tolterodine tartrate
Dosage form(s) Tablet
Route(s) of administration Oral
Drug class (WHO ATC)
  1. G Genito urinary system and sex hormones
    1. G04 Urologicals
      1. G04B Urologicals
        1. G04BD Drugs for urinary frequency and incontinence
          1. G04BD07 Tolterodine
Company MINT PHARMACEUTICALS INC
Current status Marketed
Current status date December 16, 2015
Strengths and forms
DIN Strength Dosage form(s) Current status
02423308 1 MG Tablet Marketed December 16, 2015
02423316 2 MG Tablet Marketed December 16, 2015

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.